HR 2086 RFS 
of Congress for the Office’’ after ‘‘House of Rep-
resentatives’’; and 
(4) in subparagraph (E)(ii)(bb), as so redesig-
nated, by inserting ‘‘and the authorizing committees 
of Congress for the Office’’ after ‘‘House of Rep-
resentatives’’. 
(d) REPROGRAMMING AND TRANSFER REQUESTS.—
Section 704(c)(4)(A) (21 U.S.C. 1703(c)(4)(A)) is amend-
ed by striking ‘‘$5,000,000’’ and inserting ‘‘$1,000,000’’. 
(e) POWERS
OF DIRECTOR.—Section 704(d) (21 
U.S.C. 1703(d)) is amended—
(1) in paragraph (8)(D), by striking ‘‘have been 
authorized by Congress;’’ and inserting ‘‘authorized 
by law;’’; 
(2) in paragraph (9)—
(A) by inserting ‘‘notwithstanding any 
other provision of law,’’ after ‘‘(9)’’; and 
(B) by striking ‘‘Strategy; and’’ and insert-
ing ‘‘Strategy and notify the authorizing Com-
mittees of Congress for the Office of any fund 
control notice issued;’’; 
(3) in paragraph (10), by striking ‘‘(22 U.S.C. 
2291j).’’ and inserting ‘‘(22 U.S.C. 2291j) and sec-
tion 706 of the Department of State Authorization 
Act for Fiscal Year 2003 (22 U.S.C. 229j–l);’’;
HR 2086 RFS 
(4) by adding at the end the following new 
paragraphs: 
‘‘(11) not later than August 1 of each year, 
submit to the President a report, and transmit cop-
ies of the report to the Secretary of State and the 
authorizing Committees of Congress for the Office, 
that—
‘‘(A) provides the Director’s assessment of 
which countries are major drug transit coun-
tries or major illicit drug producing countries as 
defined in section 481(e) of the Foreign Assist-
ance Act of 1961; 
‘‘(B) provides the Director’s assessment of 
whether each country identified under subpara-
graph (A) has cooperated fully with the United 
States or has taken adequate steps on its own 
to achieve full compliance with the goals and 
objectives established by the United Nations 
Convention Against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances and other-
wise has assisted in reducing the supply of il-
licit drugs to the United States; and 
‘‘(C) provides the Director’s assessment of 
whether application of procedures set forth in 
section 490(a) through (h) of the Foreign As-
HR 2086 RFS 
sistance Act of 1961, as provided in section 706 
of the Department of State Authorization Act 
for Fiscal Year 2003, is warranted with respect 
to countries the Director assesses have not co-
operated fully; and 
‘‘(12) appoint a United States Interdiction Co-
ordinator under subsection (i).’’. 
(f) UNITED STATES INTERDICTION COORDINATOR.—
Section 704 (21 U.S.C. 1703) is further amended by add-
ing at the end the following: 
‘‘(i) 
UNITED
STATES
INTERDICTION
COORDI-
NATOR.—
‘‘(1) IN GENERAL.—There shall be in the Office 
a United States Interdiction Coordinator, who shall 
be appointed by the Director and shall perform du-
ties determined by the Director with respect to co-
ordination of efforts to interdict illicit drugs from 
the United States. 
‘‘(2) APPOINTMENT.—
‘‘(A) IN GENERAL.—Notwithstanding any 
other provision of law (except subparagraph 
(B)), the Director may appoint any individual 
to serve as the United States Interdiction Coor-
dinator.
HR 2086 RFS 
‘‘(B) LIMITATION.—The Director may not 
appoint to such position any individual who 
concurrently serves as the head of any other 
Federal department or agency or any subdivi-
sion thereof with responsibility for narcotics 
interdiction activities, except the counter-
narcotics officer of the Department of Home-
land Security appointed under section 878 of 
the Homeland Security Act of 2002 (6 U.S.C. 
458).’’. 
(g) REQUIREMENT FOR SOUTH AMERICAN HEROIN 
STRATEGY.—
(1) IN GENERAL.—Not later than 90 days after 
the date of the enactment of this Act, the Director 
of National Drug Control Policy shall submit to the 
Congress a comprehensive strategy that addresses 
the increased threat from South American heroin, 
and in particular Colombian heroin. 
(2) CONTENTS.—The strategy shall—
(A) include opium eradication efforts to 
eliminate the problem at the source to prevent 
it from reoccurring before the heroin enters the 
stream of commerce; 
(B) interdiction and precursor chemical 
controls;
HR 2086 RFS 
(C) demand reduction and treatment; 
(D) provisions that ensure the mainte-
nance at current levels of efforts to eradicate 
coca in Colombia; and 
(E) assessment of the level of additional 
funding and resources necessary to simulta-
neously address the threat from South Amer-
ican heroin and the threat from Colombian 
coca. 
SEC. 4. AMENDMENTS RELATING TO COORDINATION WITH 
OTHER AGENCIES. 
Section 705 (21 U.S.C. 1704) is amended—
(1) 
in 
subsection 
(a)(1)(A), 
by 
striking 
‘‘abuse’’; 
(2) by amending paragraph (3) of subsection 
(a) to read as follows: 
‘‘(3) REQUIRED REPORTS.—
‘‘(A) SECRETARIES OF THE INTERIOR AND 
AGRICULTURE.—The Secretaries of Agriculture 
and Interior shall, by July 1 of each year, joint-
ly submit to the Director and the authorizing 
Committees of Congress for the Office an as-
sessment of the quantity of illegal drug cultiva-
tion and manufacturing in the United States on
HR 2086 RFS 
lands owned or under the jurisdiction of the 
Federal Government for the preceding year. 
‘‘(B) ATTORNEY GENERAL.—The Attorney 
General shall, by July 1 of each year, submit to 
the Director and the authorizing Committees of 
Congress for the Office information for the pre-
ceding year regarding the number and type 
of—
‘‘(i) arrests for drug violations; 
‘‘(ii) prosecutions for drug violations 
by United States Attorneys; and 
‘‘(iii) the number and type of seizures 
of drugs by each component of the Depart-
ment seizing drugs, as well as statistical 
information on the geographic areas of 
such seizures. 
‘‘(C) SECRETARY
OF
HOMELAND
SECU-
RITY.—The Secretary of Homeland Security 
shall, by July 1 of each year, submit to the Di-
rector and the authorizing Committees of Con-
gress for the Office information for the pre-
ceding year regarding—
‘‘(i) the number and type of seizures 
of drugs by each component of the Depart-
ment seizing drugs, as well as statistical
HR 2086 RFS 
information on the geographic areas of 
such seizures; and 
‘‘(ii) the number of air and maritime 
patrol hours undertaken by each compo-
nent of the Department primarily dedi-
cated to drug supply reduction missions. 
‘‘(D) SECRETARY OF DEFENSE.—The Sec-
retary of Defense shall, by July 1 of each year, 
submit to the Director and the authorizing 
Committees of Congress for the Office informa-
tion for the preceding year regarding the num-
ber of air and maritime patrol hours primarily 
dedicated to drug supply reduction missions un-
dertaken by each component of the Department 
of Defense.’’; and 
(3) in subsection (b)(2)(B), by striking ‘‘Pro-
gram.’’ and inserting ‘‘Strategy.’’. 
SEC. 5. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
Section 706 (21 U.S.C. 1705) is amended to read as 
follows:
HR 2086 RFS 
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVEL-
OPMENT AND SUBMISSION OF NATIONAL DRUG CONTROL 
STRATEGY.—
‘‘(1) IN GENERAL.—Not later than February 1 
of each year, the President shall submit to Congress 
a National Drug Control Strategy, which shall set 
forth a comprehensive plan for reducing illicit drug 
use and the consequences of illicit drug use in the 
United States by reducing the demand for illegal 
drugs, limiting the availability of illegal drugs, and 
conducting law enforcement activities with respect to 
illegal drugs. 
‘‘(2) CONTENTS.— 
‘‘(A) IN
GENERAL.—The National Drug 
Control Strategy submitted under paragraph 
(1) shall include—
‘‘(i) comprehensive, research-based, 
long-range, and quantifiable goals for re-
ducing illicit drug use and the con-
sequences of illicit drug use in the United 
States; 
‘‘(ii) annual objectives and strategy 
for demand reduction, supply reduction,
HR 2086 RFS 
and law enforcement activities, specific tar-
gets to accomplish long-range quantifiable 
reduction in illicit drug use as determined 
by the Director, and specific measurements 
to evaluate progress toward the targets 
and strategic goals; 
‘‘(iii) a strategy to reduce the avail-
ability and purity of illegal drugs and the 
level of drug-related crime in the United 
States; 
‘‘(iv) an assessment of Federal effec-
tiveness in achieving the National Drug 
Control Strategy for the previous year, in-
cluding—
‘‘(I) a specific evaluation of 
whether the objectives and targets for 
reducing illicit drug use for the pre-
vious year were met and reasons for 
the success or failure of the previous 
year’s Strategy; and 
‘‘(II) an assessment of the avail-
ability and purity of illegal drugs and 
the level of drug-related crime in the 
United States;
HR 2086 RFS 
‘‘(v) notification of any program or 
budget priorities that the Director expects 
to significantly change from the current 
Strategy over the next five years; 
‘‘(vi) a review of international, State, 
local, and private sector drug control ac-
tivities to ensure that the United States 
pursues well-coordinated and effective drug 
control at all levels of government; 
‘‘(vii) such statistical data and infor-
mation as the Director deems appropriate 
to demonstrate and assess trends relating 
to illicit drug use, the effects and con-
sequences thereof, supply reduction, de-
mand reduction, drug-related law enforce-
ment, and the implementation of the Na-
tional Drug Control Strategy; and 
‘‘(viii) a supplement reviewing the ac-
tivities of each individual National Drug 
Control Program agency during the pre-
vious year with respect to the National 
Drug Control Strategy and the Director’s 
assessment of the progress of each Na-
tional Drug Control Program agency in
HR 2086 RFS 
meeting its responsibilities under the Na-
tional Drug Control Strategy. 
‘‘(B) 
CLASSIFIED
INFORMATION.—Any 
contents of the National Drug Control Strategy 
that involve information properly classified 
under criteria established by an Executive order 
shall be presented to Congress separately from 
the rest of the National Drug Control Strategy. 
‘‘(C) SELECTION OF DATA AND INFORMA-
TION.—In selecting data and information for 
inclusion under subparagraph (A), the Director 
shall ensure—
‘‘(i) the inclusion of data and informa-
tion that will permit analysis of current 
trends against previously compiled data 
and information where the Director be-
lieves such analysis enhances long-term as-
sessment of the National Drug Control 
Strategy; and 
‘‘(ii) the inclusion of data and infor-
mation to permit a standardized and uni-
form assessment of the effectiveness of 
drug treatment programs in the United 
States.
HR 2086 RFS 
‘‘(3) PROCESS FOR DEVELOPMENT AND SUB-
MISSION.—
‘‘(A) CONSULTATION.—In developing and 
effectively implementing the National Drug 
Control Strategy, the Director—
‘‘(i) shall consult with—
‘‘(I) the heads of the National 
Drug Control Program agencies; 
‘‘(II) Congress; 
‘‘(III) State and local officials; 
‘‘(IV) private citizens and organi-
zations with experience and expertise 
in demand reduction; 
‘‘(V) private citizens and organi-
zations with experience and expertise 
in supply reduction; 
‘‘(VI) private citizens and organi-
zations with experience and expertise 
in law enforcement; and 
‘‘(VII) appropriate representa-
tives of foreign governments; 
‘‘(ii) with the concurrence of the At-
torney General, may require the El Paso 
Intelligence Center to undertake specific
HR 2086 RFS 
tasks or projects to implement the Na-
tional Drug Control Strategy; 
‘‘(iii) with the concurrence of the Di-
rector of Central Intelligence and the At-
torney General, may request that the Na-
tional Drug Intelligence Center undertake 
specific tasks or projects to implement the 
National Drug Control Strategy; and 
‘‘(iv) may make recommendations to 
the Secretary of Health and Human Serv-
ices on research that supports or advances 
the National Drug Control Strategy. 
‘‘(B) RECOMMENDATIONS.—Recommenda-
tions under subparagraph (A)(iv) may include 
recommendations of research to be performed 
at the National Institutes of Health, including 
the National Institute on Drug Abuse, or any 
other appropriate agency within the Depart-
ment of Health and Human Services. 
‘‘(C) INCLUSION IN STRATEGY.—The Na-
tional Drug Control Strategy under this sub-
section shall include a list of each entity con-
sulted under subparagraph (A)(i). 
‘‘(4) SUBMISSION OF REVISED STRATEGY.—The 
President may submit to Congress a revised Na-
HR 2086 RFS 
tional Drug Control Strategy that meets the require-
ments of this section—
‘‘(A) at any time, upon a determination by 
the President, in consultation with the Director, 
that the National Drug Control Strategy in ef-
fect is not sufficiently effective; or 
‘‘(B) if a new President or Director takes 
office. 
‘‘(b) PERFORMANCE MEASUREMENT SYSTEM.—Not 
later than February 1 of each year, the Director shall sub-
mit to Congress a description of the national drug control 
performance measurement system, designed in consulta-
tion with affected National Drug Control Program agen-
cies, that includes performance measures for the National 
Drug Control Strategy and activities of National Drug 
Control Program agencies related to the National Drug 
Control Strategy.’’. 
SEC. 6. HIGH INTENSITY DRUG TRAFFICKING AREAS PRO-
GRAM. 
(a) IN GENERAL.—Section 707 (21 U.S.C. 1706) is 
amended to read as follows: 
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
‘‘(a) ESTABLISHMENT.—There is established in the 
Office a program to be known as the High Intensity Drug
HR 2086 RFS 
Trafficking Areas Program (in this section referred to as 
the ‘Program’). 
‘‘(b) PURPOSES.—The purposes of the Program are 
the following: 
‘‘(1) To reduce drug availability and facilitate 
cooperative efforts between Federal, State, and local 
law enforcement agencies in areas with significant 
drug trafficking problems that harmfully impact 
other parts of the Nation. 
‘‘(2) To provide assistance to agencies to come 
together to assess regional threats, design coordi-
nated strategies to combat those threats, share intel-
ligence, and develop and implement coordinated ini-
tiatives to implement the strategies. 
‘‘(c) DESIGNATION.—The Director, upon consulta-
tion with the Attorney General, the Secretary of the 
Treasury, the Secretary of Homeland Security, heads of 
the National Drug Control Program agencies, and the 
Governor of each applicable State, may designate any 
specified area of the United States as a high intensity 
drug trafficking area. 
‘‘(d) FACTORS FOR CONSIDERATION.—
‘‘(1) IN GENERAL.—In considering whether to 
designate an area under this section as a high inten-
sity drug trafficking area, the Director shall con-
HR 2086 RFS 
sider, in addition to such other criteria as the Direc-
tor considers to be appropriate, the extent to 
which—
‘‘(A) the area is a major center of illegal 
drug production, manufacturing, importation, 
or distribution for the United States as com-
pared to other areas of the United States; 
‘‘(B) State and local law enforcement 
agencies have committed resources to respond 
to the drug trafficking problem in the area, 
thereby indicating a determination to respond 
aggressively to the problem; 
‘‘(C) drug production, manufacturing, im-
portation, or distribution in the area is having 
a significant harmful impact in other areas of 
the United States; and 
‘‘(D) a significant increase in allocation of 
Federal resources is necessary to respond ade-
quately to drug-related activities in the area. 
‘‘(2) CONSIDERATIONS.—For purposes of para-
graph (1)(A), in considering whether an area is a 
major center of illegal drug production, manufac-
turing, importation, or distribution as compared to 
other areas of the United States, the Director shall 
consider—
HR 2086 RFS 
‘‘(A) the quantity of illicit drug traffic en-
tering or transiting the area originating in for-
eign countries; 
‘‘(B) the quantity of illicit drugs produced 
in the area; 
‘‘(C) the number of Federal, State, and 
local arrests, prosecutions, and convictions for 
drug trafficking and distribution offenses in the 
area; 
‘‘(D) the degree to which the area is a cen-
ter for the activities of national drug trafficking 
organizations; and 
‘‘(E) such other criteria as the Director 
considers appropriate. 
‘‘(e) SOUTHWEST BORDER.—The Director may not 
designate any county contiguous to the international land 
border with Mexico as part of any high intensity drug traf-
ficking area other than as part of a single Southwest Bor-
der high intensity drug trafficking area. 
‘‘(f) REMOVAL FROM DESIGNATION.—The Director 
may remove an area or portion of an area from designa-
tion as a high intensity drug trafficking area under this 
section upon determination that the area or portion of an 
area no longer is a high intensity drug trafficking area, 
considering the factors in subsections (d) and (e) in addi-
HR 2086 RFS 
tion to such other criteria as the Director considers to be 
appropriate. 
‘‘(g) AUTHORITY OF THE DIRECTOR.—After making 
such a designation and in order to provide Federal assist-
ance to the area so designated, the Director may—
‘‘(1) obligate such sums as appropriated for the 
Program, in accordance with subsection (h); 
‘‘(2) direct the temporary reassignment of Fed-
eral personnel to such area, subject to the approval 
of the head of the department or agency that em-
ploys such personnel; and 
‘‘(3) take any other action authorized under 
section 704 to provide increased Federal assistance 
to those areas. 
‘‘(h) ALLOCATION OF FUNDING.—In obligating sums 
appropriated for the Program, the Director shall comply 
with the following: 
‘‘(1) 30 PERCENT SET ASIDE.—The Director 
shall expend no less than 30 percent of the amounts 
appropriated under this section in the seven high in-
tensity drug trafficking areas (excluding the South-
west Border high intensity drug trafficking area) for 
which the Director determines that Program activi-
ties with respect to such areas will have the greatest
HR 2086 RFS 
impact on reducing overall drug traffic in the United 
States. 
‘‘(2) 25 PERCENT SET ASIDE.—The Director 
shall expend no less than 25 percent of the amounts 
appropriated under this section in nine other high 
intensity drug trafficking areas (excluding the 
Southwest Border high intensity drug trafficking 
area) for which the Director determines that Pro-
gram activities with respect to such areas will have 
the next greatest impact on reducing overall drug 
traffic in the United States. 
‘‘(3) SOUTHWEST BORDER AREA.—
‘‘(A) 20 PERCENT SET ASIDE.—The Direc-
tor shall expend no less than 20 percent of the 
amounts appropriated under this section in the 
Southwest Border high intensity drug traf-
ficking area. 
‘‘(B) REALLOCATION WITHIN AREA.—The 
executive committee of the Southwest Border 
high intensity drug trafficking area may reallo-
cate up to five percent of the total funds allo-
cated to that area among its components, with 
the approval of the Director. 
‘‘(4) REMAINING
AREAS.—The Director shall 
expend no less than 10 percent of the amounts ap-
HR 2086 RFS 
propriated under this section in the remaining high 
intensity drug trafficking areas. 
‘‘(5) DISCRETIONARY EXPENDITURES.—
‘‘(A) IN
GENERAL.—In addition to the 
amounts 
allocated 
under 
paragraphs 
(1) 
through (4) the Director may expend 15 per-
cent of the amounts appropriated under this 
section on a discretionary basis. 
‘‘(B) CONSIDERATION OF IMPACT.—In al-
locating funds under this paragraph, the Direc-
tor shall consider—
‘‘(i) the impact of activities funded on 
reducing overall drug traffic in the United 
States; 
‘‘(ii) performance measures of effec-
tiveness; and 
‘‘(iii) such other criteria as the Direc-
tor considers appropriate. 
‘‘(i) USE OF FUNDS.—
‘‘(1) LIMITATION.—No funds appropriated for 
the Program shall be expended for drug treatment 
programs. 
‘‘(2) LIMITATION
ON
APPLICABILITY.—Para-
graph (1) shall not apply with respect to the
HR 2086 RFS 
Baltimore/Washington high intensity drug traf-
ficking area. 
‘‘(j) TERRORISM ACTIVITIES.—
‘‘(1) ASSISTANCE AUTHORIZED.—The Director 
may authorize use of resources available for the Pro-
gram to assist Federal, State, and local law enforce-
ment agencies in investigations and activities related 
to terrorism and prevention of terrorism, especially 
but not exclusively where such investigations are re-
lated to drug trafficking. 
‘‘(2) LIMITATION.—The Director shall ensure—
‘‘(A) that assistance provided under para-
graph (1) remains incidental to the purpose of 
the Program to reduce drug availability and 
carry out drug-related law enforcement activi-
ties; and 
‘‘(B) that significant resources of the Pro-
gram are not redirected to activities exclusively 
related to terrorism. 
‘‘(k) BOARD REPRESENTATION.—None of the funds 
appropriated under this section may be expended for any 
high intensity drug trafficking area, or for a partnership 
under the Program, if the executive board or equivalent 
governing committee with respect to such area or partner-
ship is not comprised of equal voting representation be-
HR 2086 RFS 
tween representatives of Federal law enforcement agencies 
and representatives of State and local law enforcement 
agencies. 
‘‘(l) ROLE OF DRUG ENFORCEMENT ADMINISTRA-
TION.—The Director, in consultation with the Attorney 
General, shall ensure that a representative of the Drug 
Enforcement Administration is included in the Intelligence 
Support Center for each high intensity drug trafficking 
area. 
‘‘(m) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to the Office of National 
Drug Control Policy to carry out this section—
‘‘(1) $230,000,000 for fiscal year 2004; 
‘‘(2) $240,000,000 for each of fiscal years 2005 
and 2006; and 
‘‘(3) $250,000,000 for each of fiscal years 2007 
and 2008.’’. 
(b) REVIEW OF CURRENT AREAS.—Within one year 
after the date of enactment of this Act, the Director of 
National Drug Control Policy shall—
(1) review each of the areas currently des-
ignated as a high intensity drug trafficking area to 
determine whether it continues to warrant designa-
tion as a high intensity drug trafficking area, con-
sidering the factors in section 707(d) of the Office
HR 2086 RFS 
of National Drug Control Policy Reauthorization Act 
of 1998, as amended by this section, in addition to 
such other criteria as the Director considers to be 
appropriate; and 
(2) terminate such description for an area or 
portion of an area determined to no longer warrant 
designation. 
SEC. 7. FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS. 
(a) SHORT TITLE.—This section may be cited as the 
‘‘Dawson Family Community Protection Act’’. 
(b) FINDINGS.—Congress finds the following: 
(1) In the early morning hours of October 16, 
2002, the home of Carnell and Angela Dawson was 
firebombed 
in 
apparent 
retaliation 
for 
Mrs. 
Dawson’s notification of police about persistent drug 
distribution activity in their East Baltimore City 
neighborhood. 
(2) The arson claimed the lives of Mr. and Mrs. 
Dawson and their 5 young children, aged 9 to 14. 
(3) The horrific murder of the Dawson family 
is a stark example of domestic narco-terrorism. 
(4) In all phases of counter-narcotics law en-
forcement—from prevention to investigation to pros-
HR 2086 RFS 
ecution to reentry—the voluntary cooperation of or-
dinary citizens is a critical component. 
(5) Voluntary cooperation is difficult for law en-
forcement officials to obtain when citizens feel that 
cooperation carries the risk of violent retaliation by 
illegal drug trafficking organizations and their affili-
ates. 
(6) Public confidence that law enforcement is 
doing all it can to make communities safe is a pre-
requisite for voluntary cooperation among people 
who may be subject to intimidation or reprisal (or 
both). 
(7) Witness protection programs are insufficient 
on their own to provide security because many indi-
viduals and families who strive every day to make 
distressed neighborhoods livable for their children, 
other relatives, and neighbors will resist or refuse of-
fers of relocation by local, State, and Federal pros-
ecutorial agencies and because, moreover, the contin-
ued presence of strong individuals and families is 
critical to preserving and strengthening the social 
fabric in such communities. 
(8) Where (as in certain sections of Baltimore 
City) interstate trafficking of illegal drugs has severe 
ancillary local consequences within areas designated
HR 2086 RFS 
as high intensity drug trafficking areas, it is impor-
tant that supplementary High Intensity Drug Traf-
ficking Areas Program funds be committed to sup-
port initiatives aimed at making the affected com-
munities safe for the residents of those communities 
and encouraging their cooperation with local, State, 
and Federal law enforcement efforts to combat ille-
gal drug trafficking. 
(c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS.—Section 707 (21 U.S.C. 1706) is 
further amended in subsection (h) by adding at the end 
the following new paragraph: 
‘‘(6) SPECIFIC PURPOSES.—
‘‘(A) IN GENERAL.—The Director shall en-
sure that, of the amounts appropriated for a 
fiscal year for the Program, at least $1,000,000 
is used in high intensity drug trafficking areas 
with severe neighborhood safety and illegal drug 
distribution problems. 
‘‘(B) REQUIRED
USES.—The funds used 
under subparagraph (A) shall be used—
‘‘(i) to ensure the safety of neighbor-
hoods and the protection of communities, 
including the prevention of the intimida-
HR 2086 RFS 
tion of potential witnesses of illegal drug 
distribution and related activities; and 
‘‘(ii) to combat illegal drug trafficking 
through such methods as the Director con-
siders appropriate, such as establishing or 
operating (or both) a toll-free telephone 
hotline for use by the public to provide in-
formation about illegal drug-related activi-
ties.’’. 
SEC. 8. AMENDMENTS RELATING TO COUNTER-DRUG TECH-
NOLOGY ASSESSMENT CENTER. 
(a) CHIEF SCIENTIST.—Section 708(b) (21 U.S.C. 
1707(b)) is amended—
(1) in the heading by striking ‘‘DIRECTOR OF 
TECHNOLOGY.—’’ 
and 
inserting 
‘‘CHIEF
SCI-
ENTIST.—’’; and 
(2) by striking ‘‘Director of Technology,’’ and 
inserting ‘‘Chief Scientist,’’. 
(b) ADDITIONAL RESPONSIBILITIES OF DIRECTOR.—
Section 708(c) (21 U.S.C. 1707(c)) is amended to read 
as follows: 
‘‘(c) ADDITIONAL RESPONSIBILITIES OF THE DIREC-
TOR OF NATIONAL DRUG CONTROL POLICY.—
‘‘(1) 
IN
GENERAL.—The 
Director, 
acting 
through the Chief Scientist shall—
HR 2086 RFS 
‘‘(A) identify and define the short-, me-
dium-, and long-term scientific and techno-
logical needs of Federal, State, and local law 
enforcement agencies relating to drug enforce-
ment, including—
‘‘(i) advanced surveillance, tracking, 
and radar imaging; 
‘‘(ii) electronic support measures; 
‘‘(iii) communications; 
‘‘(iv) data fusion, advanced computer 
systems, and artificial intelligence; and 
‘‘(v) chemical, biological, radiological 
(including neutron, electron, and graviton), 
and other means of detection; 
‘‘(B) identify demand reduction (including 
drug prevention) basic and applied research 
needs and initiatives, in consultation with af-
fected National Drug Control Program agen-
cies, including—
‘‘(i) improving treatment through 
neuroscientific advances; 
‘‘(ii) improving the transfer of bio-
medical research to the clinical setting; and 
‘‘(iii) in consultation with the Na-
tional Institute on Drug Abuse and the
HR 2086 RFS 
Substance Abuse and Mental Health Serv-
ices Administration, and through inter-
agency agreements or grants, examining 
addiction and rehabilitation research and 
the application of technology to expanding 
the effectiveness or availability of drug 
treatment; 
‘‘(C) make a priority ranking of such needs 
identified in subparagraphs (A) and (B) accord-
ing to fiscal and technological feasibility, as 
part of a National Counter-Drug Enforcement 
Research and Development Program; 
‘‘(D) oversee and coordinate counter-drug 
technology initiatives with related activities of 
other Federal civilian and military departments; 
‘‘(E) oversee and coordinate a technology 
transfer program for the transfer of technology 
to State and local law enforcement agencies; 
and 
‘‘(F) pursuant to the authority of the Di-
rector of National Drug Control Policy under 
section 704, submit requests to Congress for 
the reprogramming or transfer of funds appro-
priated for counter-drug technology research 
and development.
HR 2086 RFS 
‘‘(2) PRIORITIES
IN
TRANSFERRING
TECH-
NOLOGY.—In transferring technology under the au-
thority of paragraph (1)(E), the Chief Scientist shall 
give priority, in transferring technologies most likely 
to assist in drug interdiction and border enforce-
ment, to State, local, and tribal law enforcement 
agencies in southwest border areas and northern 
border areas with significant traffic in illicit drugs. 
‘‘(3) LIMITATION ON AUTHORITY.—The author-
ity granted to the Director under this subsection 
shall not extend to the award of contracts, manage-
ment of individual projects, or other operational ac-
tivities.’’. 
(c) ASSISTANCE FROM SECRETARY OF HOMELAND 
SECURITY.—Section 708(d) (21 U.S.C. 1707(d)) is 
amended by inserting ‘‘, the Secretary of Homeland Secu-
rity,’’ after ‘‘The Secretary of Defense’’. 
SEC. 9. REPEALS. 
The following provisions are repealed: 
(1) Sections 709 and 711 (21 U.S.C. 1708 and 
1710). 
(2) Section 6073 of the Asset Forfeiture 
Amendments Act of 1988 (21 U.S.C. 1509).
HR 2086 RFS 
SEC. 10. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
(a) IN GENERAL.—The Act is further amended by 
inserting after section 708 the following: 
‘‘SEC. 709. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
‘‘(a) IN GENERAL.—The Director shall conduct a na-
tional media campaign in accordance with this section for 
the purpose of reducing and preventing illicit drug use 
among young people in the United States, through mass 
media advertising. 
‘‘(b) USE OF FUNDS.—
‘‘(1) IN GENERAL.—Amounts made available to 
carry out this section for the media campaign may 
only be used for the following: 
‘‘(A) The purchase of media time and 
space. 
‘‘(B) Creative and talent costs. 
‘‘(C) Advertising production costs. 
‘‘(D) Testing and evaluation of advertising. 
‘‘(E) Evaluation of the effectiveness of the 
media campaign. 
‘‘(F) The negotiated fees for the winning 
bidder on requests for proposals issued either 
by the Office or its designee for purposes other-
wise authorized in this section.
HR 2086 RFS 
‘‘(G) Partnerships with community, civic, 
and professional groups and government organi-
zations related to the media campaign. 
‘‘(H) Entertainment industry outreach, 
interactive outreach, media projects and activi-
ties, public information, news media outreach, 
and corporate sponsorship and participation. 
‘‘(I) Operational and management ex-
penses. 
‘‘(2) SPECIFIC REQUIREMENTS.—
‘‘(A) CREATIVE SERVICES.—
‘‘(i) In using amounts for creative and 
talent costs under paragraph (1)(B), the 
Director shall use creative services donated 
at no cost to the Government wherever fea-
sible and may only procure creative serv-
ices for advertising—
‘‘(I) responding to high-priority 
or emergent campaign needs that can-
not timely be obtained at no cost; or 
‘‘(II) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot reasonably be obtained at 
no cost.
HR 2086 RFS 
‘‘(ii) No more than $1,000,000 may 
be expended under this section each fiscal 
year on creative services, except that the 
Director may expend up to $2,000,000 in 
a fiscal year on creative services to meet 
urgent needs of the media campaign with 
advance approval from the Committee on 
Appropriations of the House of Represent-
atives and of the Senate upon a showing of 
the circumstances causing such urgent 
needs of the media campaign. 
‘‘(B) TESTING AND EVALUATION OF AD-
VERTISING.—In using amounts for testing and 
evaluation of advertising under paragraph 
(1)(D), the Director shall test all advertise-
ments prior to use in the media campaign to 
ensure that the advertisements are effective and 
meet industry-accepted standards. The Director 
may waive this requirement for advertisements 
using no more than 10 percent of the purchase 
of advertising time purchased under this section 
in an fiscal year and no more than 10 percent 
of the advertising space purchased under this 
section in a fiscal year, if the advertisements re-
spond to emergent and time-sensitive campaign
HR 2086 RFS 
‘‘(ii) ensure that the effectiveness of 
the media campaign is evaluated in a man-
ner that enables consideration of whether 
the media campaign has contributed to re-
duction of illicit drug use among youth and 
such other measures of evaluation as the 
Director determines are appropriate. 
‘‘(3) PURCHASE
OF
ADVERTISING
TIME
AND 
SPACE.—For each fiscal year, not less than 77 per-
cent of the amounts appropriated under this section 
shall be used for the purchase of advertising time 
and space for the media campaign, subject to the 
following exceptions: 
‘‘(A) In any fiscal year for which less than 
$125,000,000 is appropriated for the media 
campaign, not less than 82 percent of the 
amounts appropriated under this section shall 
be used for the purchase of advertising time 
and space for the media campaign. 
‘‘(B) In any fiscal year for which more 
than $195,000,000 is appropriated under this 
section, not less than 72 percent shall be used 
for advertising production costs and the pur-
chase of advertising time and space for the 
media campaign.
HR 2086 RFS 
‘‘(c) ADVERTISING.—In carrying out this section, the 
Director shall devote sufficient funds to the advertising 
portion of the national media campaign to meet the goals 
of the campaign. 
‘‘(d) PROHIBITIONS.—None of the amounts made 
available under subsection (b) may be obligated or ex-
pended for any of the following: 
‘‘(1) To supplant current antidrug community-
based coalitions. 
‘‘(2) To supplant pro bono public service time 
donated by national and local broadcasting networks 
for other public service campaigns. 
‘‘(3) For partisan political purposes, or express 
advocacy in support of or to defeat any clearly iden-
tified candidate, clearly identified ballot initiative, or 
clearly identified legislative or regulatory proposal. 
‘‘(4) To fund advertising that features any 
elected officials, persons seeking elected office, cabi-
net level officials, or other Federal officials employed 
pursuant to section 213 of Schedule C of title 5, 
Code of Federal Regulations. 
‘‘(5) To fund advertising that does not contain 
a primary message intended to reduce or prevent il-
licit drug use.
HR 2086 RFS 
‘‘(6) To fund advertising containing a primary 
message intended to promote support for the media 
campaign or private sector contributions to the 
media campaign. 
‘‘(e) MATCHING REQUIREMENT.—
‘‘(1) IN
GENERAL.—Amounts made available 
under subsection (b) shall be matched by an equal 
amount of non-Federal funds for the media cam-
paign, or be matched with in-kind contributions of 
the same value. 
‘‘(2) NO-COST MATCH ADVERTISING DIRECT RE-
LATIONSHIP REQUIREMENT.—The Director shall en-
sure that at least 70 percent of no-cost match adver-
tising provided directly relates to substance abuse 
prevention consistent with the specific purposes of 
the media campaign, except that in any fiscal year 
in which less than $125,000,000 is appropriated to 
the media campaign, the Director shall ensure that 
at least 85 percent of no-cost match advertising di-
rectly relates to substance abuse prevention con-
sistent with the specific purposes of the media cam-
paign. 
‘‘(3) NO-COST
MATCH
ADVERTISING
NOT
DI-
RECTLY RELATED.—The Director shall ensure that 
no-cost match advertising that does not directly re-
HR 2086 RFS 
late to substance abuse prevention includes a clear 
antidrug message. Such message is not required to 
be the primary message of the match advertising. 
‘‘(f) FINANCIAL
AND
PERFORMANCE
ACCOUNT-
ABILITY.—The Director shall cause to be performed—
‘‘(1) audits and reviews of costs of the media 
campaign pursuant to section 304C of the Federal 
Property and Administrative Services Act of 1949 
(41 U.S.C. 254d); and 
‘‘(2) an audit of the cost of the media campaign 
described in section 306 of such Act (41 U.S.C. 
256). 
‘‘(g) STRATEGIC GUIDANCE AND DONATIONS.—The 
Partnership for a Drug Free America shall serve as the 
primary outside strategic advisor to the media campaign 
and be responsible for coordinating donations of creative 
and other services to the campaign, except with respect 
to advertising created using funds permitted in subsection 
(b). The Director shall inform the Partnership for a Drug 
Free America of the strategic goals of the campaign and 
consider advice from the Partnership for a Drug Free 
America on media campaign strategy. 
‘‘(h) REPORT
TO CONGRESS.—The Director shall 
submit on an annual basis a report to Congress that de-
scribes—
HR 2086 RFS 
‘‘(1) the strategy of the media campaign and 
whether specific objectives of the media campaign 
were accomplished; 
‘‘(2) steps taken to ensure that the media cam-
paign operates in an effective and efficient manner 
consistent with the overall strategy and focus of the 
media campaign; 
‘‘(3) plans to purchase advertising time and 
space; 
‘‘(4) policies and practices implemented to en-
sure that Federal funds are used responsibly to pur-
chase advertising time and space and eliminate the 
potential for waste, fraud, and abuse; and 
‘‘(5) all contracts entered into with a corpora-
tion, partnership, or individual working on behalf of 
the media campaign. 
‘‘(i) LOCAL TARGET REQUIREMENT.—The Director 
shall, to the maximum extent feasible, use amounts made 
available under this section for media that focuses on, or 
includes specific information on, prevention or treatment 
resources for consumers within specific local areas. 
‘‘(j) PREVENTION OF MARIJUANA USE.—
‘‘(1) FINDINGS.—The Congress finds the fol-
lowing:
HR 2086 RFS 
‘‘(A) 60 percent of adolescent admissions 
for drug treatment are based on marijuana use. 
‘‘(B) Potency levels of contemporary mari-
juana, particularly hydroponically grown mari-
juana, are significantly higher than in the past, 
rising from under 1 percent of THC in the mid-
1970s to as high as 30 percent today. 
‘‘(C) Contemporary research has dem-
onstrated that youths smoking marijuana early 
in life may be up to five times more likely to 
use hard drugs. 
‘‘(D) Contemporary research has dem-
onstrated clear detrimental effects in adolescent 
educational achievement resulting from mari-
juana use. 
‘‘(E) Contemporary research has dem-
onstrated clear detrimental effects in adolescent 
brain development resulting from marijuana 
use. 
‘‘(F) An estimated 9,000,000 Americans a 
year drive while under the influence of illegal 
drugs, including marijuana. 
‘‘(G) Marijuana smoke contains 50 to 70 
percent more of certain cancer causing chemi-
cals than tobacco smoke.